3 Persisting problems in tuberculosis
- 1 January 1998
- book chapter
- Published by Elsevier
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Success rates for new drugs entering clinical testing in the United StatesClinical Pharmacology & Therapeutics, 1995
- Recurrent cutaneous leishmaniasis: A role for persistent parasites?Parasitology Today, 1994
- CDlb restricts the response of human CD4−8−T lymphocytes to a microbial antigenNature, 1992
- Racial Differences in Susceptibility to Infection byMycobacterium tuberculosisNew England Journal of Medicine, 1990
- A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1989
- The protective effect of BCG vaccination as indicated by autopsy studiesTubercle, 1979
- The sterilizing value of rifampicin and pyrazinamide in experimental short course chemotherapyTubercle, 1978
- The immunity conferred by effective BCG and vole bacillus vaccines, in relation to individual variations in induced tuberculin sensitivity and to technical variations in the vaccinesTubercle, 1967
- Measles endemicity in insular populations: Critical community size and its evolutionary implicationJournal of Theoretical Biology, 1966
- BCG vaccination of Indian infants in Saskatchewan: A study carried out with financial assistance from the National Research Council of CanadaTubercle, 1949